Anna Martling
Directeur/Membre du Conseil chez BACTIGUARD HOLDING AB
Fortune : 22 080 $ au 30/04/2024
Postes actifs de Anna Martling
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BACTIGUARD HOLDING AB | Directeur/Membre du Conseil | 15/05/2019 | - |
| Independent Dir/Board Member | 15/05/2019 | - | |
| Karolinska Institutet | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - | |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 01/01/2019 | - |
Historique de carrière de Anna Martling
Anciens postes connus de Anna Martling
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Cancer Society In Stockholm | Directeur/Membre du Conseil | - | - |
| The Swedish Cancer Society | Directeur/Membre du Conseil | - | - |
| Radiumhemmets Forskningsfonder | Directeur/Membre du Conseil | - | - |
Formation de Anna Martling
| Karolinska Institutet | Doctorate Degree |
Statistiques
Internationale
| Suède | 7 |
Opérationnelle
| Director/Board Member | 6 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 2 |
| Distribution Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BACTIGUARD HOLDING AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
| The Swedish Cancer Society | |
Bactiguard AB
Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Distribution Services |
| Radiumhemmets Forskningsfonder | |
| Cancer Society In Stockholm |
- Bourse
- Insiders
- Anna Martling
- Expérience